There are 2789 resources available
635P - Association of ceramide metabolism with resistance to androgen receptor signalling inhibitors in metastatic prostate cancer
Presenter: Hui-Ming Lin
Session: ePoster Display
636P - A comparative analysis of prostate cancer short-term recurrence risk forecast performance between 8-gene signature and commercial panels
Presenter: Jinan Guo
Session: ePoster Display
638P - Evaluating the contribution of virtual peer-led support to comprehensive prostate cancer (PCa) care: The AnCan experience
Presenter: Herbert Geller
Session: ePoster Display
640TiP - Phase Ib/II trial of pembrolizumab (pembro) + lenvatinib combination therapy in patients (pts) with adenocarcinoma metastatic castration-resistant prostate cancer (mCRPC) or treatment-emergent neuroendocrine mCRPC (t-NE): KEYNOTE-365 cohorts E and F
Presenter: Gero Kramer
Session: ePoster Display
1384P - DKN-01 in combination with tislelizumab and chemotherapy as a first-line therapy in unselected patients with advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial
Presenter: Samuel Klempner
Session: ePoster Display